DSM
DSM is a multinational company that supports art and culture as part of its social and cultural responsibility. The company aims to generate value for society by integrating sustainability into its business activities and promoting a positive, attractive, and inspiring work environment through its art collection. DSM is also involved in the development of cannabinoid-based therapies, offering innovative solutions like CBtru® to enhance patient care and streamline drug development.
What We Do
DSM offers a unique innovation platform for cannabinoid-based therapies, powered by leading-edge technical capabilities, clinical study proficiency, and a robust cannabidiol (CBD) API offering. This includes the CBtru® solution, designed to overcome bioavailability challenges and optimize patient convenience and compliance.